Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

Zydus will focus on state-of-the-art manufacturing capabilities that will enable high quality solutions for patients with cutting-edge research and innovation, reports Financial Express.

India's Zydus Lifesciences said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical for 256.8 million ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Pharma major, Zydus Lifesciences on Wednesday said that it has launched ANVIMO (Letermovir), a new and innovative treatment ...